InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-12.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Seizinger Bernd R., Director. Insider active across 2 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 12 filings have been recorded. Split: 5 buys · 0 sell. Total volume traded: €168k. Activity tracked since 30 June 2021. The latest transaction was filed on 11 October 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
17,000 sharesCommon SharesSEC:0000912282-26-000902:0
3,135 sharesCommon StockSEC:0001104659-26-075278:0
10,000 shares@ US$2.6820.8% of flowCommon StockSEC:0001104659-24-108377:0
Ideal exit: 8 Jul 2025 (T+270)
1,045 shares0Common StockSEC:0001104659-24-073950:0
6,860 shares@ US$7.2938.8% of flowCommon StockSEC:0001104659-24-034672:0
Ideal exit: 8 Dec 2024 (T+270)
17,000 shares@ US$3.14100.0% of flowCommon SharesSEC:0000912282-23-000385:0
Ideal exit: 18 Jun 2024 (T+270)
500 shares0Common StockSEC:0001104659-23-095016:0
4,068 shares@ US$3.629411.7% of flowCommon StockSEC:0001104659-23-069421:0
Ideal exit: 2 Mar 2024 (T+270)
5,995 shares0Common StockSEC:0001104659-22-084775:0
50,000 shares@ US$0.710.57% mcap100.0% of flowCommon StockSEC:0001104659-22-062920:0
Ideal exit: 12 Feb 2023 (T+270)
4,610 shares0Common StockSEC:0001567619-21-012872
4,610 shares0Common StockSEC:0001567619-21-012872:0
12 of 12 declarations
About Seizinger Bernd R.
Bernd R. Seizinger is a Director at Aprea Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. Bernd brings expertise in the biopharmaceutical sector, which is essential for guiding Aprea's product development initiatives. His commitment to innovation and improving healthcare is crucial for the long-term success of the company.
